1. Home
  2. ITOS vs VBNK Comparison

ITOS vs VBNK Comparison

Compare ITOS & VBNK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ITOS
  • VBNK
  • Stock Information
  • Founded
  • ITOS 2011
  • VBNK 1980
  • Country
  • ITOS United States
  • VBNK Canada
  • Employees
  • ITOS N/A
  • VBNK N/A
  • Industry
  • ITOS Biotechnology: Biological Products (No Diagnostic Substances)
  • VBNK Commercial Banks
  • Sector
  • ITOS Health Care
  • VBNK Finance
  • Exchange
  • ITOS Nasdaq
  • VBNK Nasdaq
  • Market Cap
  • ITOS 446.6M
  • VBNK 370.1M
  • IPO Year
  • ITOS 2020
  • VBNK 2021
  • Fundamental
  • Price
  • ITOS $10.11
  • VBNK $10.78
  • Analyst Decision
  • ITOS Hold
  • VBNK Strong Buy
  • Analyst Count
  • ITOS 6
  • VBNK 4
  • Target Price
  • ITOS $10.40
  • VBNK $17.50
  • AVG Volume (30 Days)
  • ITOS 1.6M
  • VBNK 70.7K
  • Earning Date
  • ITOS 08-06-2025
  • VBNK 09-04-2025
  • Dividend Yield
  • ITOS N/A
  • VBNK 0.66%
  • EPS Growth
  • ITOS N/A
  • VBNK N/A
  • EPS
  • ITOS N/A
  • VBNK 0.79
  • Revenue
  • ITOS N/A
  • VBNK $79,960,487.00
  • Revenue This Year
  • ITOS N/A
  • VBNK $9.02
  • Revenue Next Year
  • ITOS N/A
  • VBNK $42.18
  • P/E Ratio
  • ITOS N/A
  • VBNK $13.56
  • Revenue Growth
  • ITOS 177.89
  • VBNK N/A
  • 52 Week Low
  • ITOS $4.80
  • VBNK $8.51
  • 52 Week High
  • ITOS $18.13
  • VBNK $18.38
  • Technical
  • Relative Strength Index (RSI)
  • ITOS 53.14
  • VBNK 43.90
  • Support Level
  • ITOS $10.08
  • VBNK $11.00
  • Resistance Level
  • ITOS $10.17
  • VBNK $11.16
  • Average True Range (ATR)
  • ITOS 0.04
  • VBNK 0.34
  • MACD
  • ITOS -0.02
  • VBNK -0.07
  • Stochastic Oscillator
  • ITOS 35.29
  • VBNK 36.96

About ITOS iTeos Therapeutics Inc.

ITeos Therapeutics Inc is a biopharmaceutical company. It designs novel product candidates with optimized pharmacologic properties to improve clinical outcomes by restoring the immune response against cancer. The company's product candidates include EOS-850 which is an Adenosine A2A receptor-specific antagonist, and EOS-448 which is an ADCC-enabled, anti-TIGIT immune checkpoint blocking antibody among other drug candidates.

About VBNK VersaBank

VersaBank is a Canadian Schedule I chartered bank with a difference. It has 3 operating segments: Digital Banking Canada, Digital Banking USA and DRTC. It's, cloud-based, business-to-business deposit and lending model provides valued-added solutions to Canadian financial intermediary partners, enabling them to focus on growing their own businesses faster and more profitably. It obtains all of its deposits and provides the majority of its loans and leases electronically, with deposit and lending solutions for financial intermediaries that allow them to excel in their core businesses. In addition, leveraging its internally developed IT security software and capabilities, Company established a wholly owned, subsidiary. Geographically located in Canada and USA.

Share on Social Networks: